Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiuning Le

Showing results (51-60 of 179) with videos related to

Pageof 18
Sort By:
Heliyon|July 3, 2023
AI in drug discovery and its clinical relevanceRizwan Qureshi, Muhammad Irfan, Taimoor Muzaffar Gondal, et al.
International Journal of Molecular Sciences|May 13, 2023
Machine Learning Models for the Identification of Prognostic and Predictive Cancer Biomarkers: A Systematic ReviewQasem Al-Tashi, Maliazurina B Saad, Amgad Muneer, et al.
Cancers|December 23, 2022
<i>TP53</i> Co-Mutation Status Association with Clinical Outcomes in Patients with <i>EGFR</i>-Mutant Non-Small Cell Lung CancerXiuning Le, Cliff Molife, Mark S Leusch, et al.
Clinical Lung Cancer|March 11, 2022
Safety of MET Tyrosine Kinase Inhibitors in Patients With MET Exon 14 Skipping Non-small Cell Lung Cancer: A Clinical ReviewAlexis Cortot, Xiuning Le, Egbert Smit, et al.
Future Oncology (London, England)|March 31, 2023
Plain language summary of the development of tepotinib: a treatment for a subtype of non-small cell lung cancer called <i>MET</i> exon 14 skippingJohn Hallick, Anne-Marie Baird, Gerald Falchook, et al.
CA: a Cancer Journal for Clinicians|July 17, 2025
Personalized care for patients with EGFR-mutant nonsmall cell lung cancer: Navigating early to advanced disease managementMaxime Borgeaud, Timothée Olivier, Jair Bar, et al.
JCO Precision Oncology|June 18, 2026
Real-World Patient Characteristics, Mutational Landscape, and Outcomes in Advanced/Metastatic <i>HER2</i>-Mutant Non-Small Cell Lung CancerChristine M Lovly, Christina Baik, Misako Nagasaka, et al.
Journal of Thoracic Disease|September 4, 2018
A consensus on the role of osimertinib in non-small cell lung cancer from the AME Lung Cancer Collaborative GroupTao Jiang, Chunxia Su, Shengxiang Ren, et al.
European Journal of Cell Biology|June 24, 2009
Interaction of SH3P13 and DYDC1 protein: a germ cell component that regulates acrosome biogenesis during spermiogenesisShuchun Li, Yuan Qiao, Qian Di, et al.
European Journal of Cell Biology|December 1, 2018
Corrigendum to "Interaction of SH3P13 and DYDC1 protein: a germ cell component that regulates acrosome biogenesis during spermiogenesis" [Eur. J. Cell Biol. 88 (2009) 509-520]Shuchun Li, Yuan Qiao, Qian Di, et al.
Pageof 18

Showing results (51-60 of 179) with videos related to

Sort By:
Pageof 18
Heliyon|July 3, 2023
AI in drug discovery and its clinical relevanceRizwan Qureshi, Muhammad Irfan, Taimoor Muzaffar Gondal, et al.
International Journal of Molecular Sciences|May 13, 2023
Machine Learning Models for the Identification of Prognostic and Predictive Cancer Biomarkers: A Systematic ReviewQasem Al-Tashi, Maliazurina B Saad, Amgad Muneer, et al.
Cancers|December 23, 2022
<i>TP53</i> Co-Mutation Status Association with Clinical Outcomes in Patients with <i>EGFR</i>-Mutant Non-Small Cell Lung CancerXiuning Le, Cliff Molife, Mark S Leusch, et al.
Clinical Lung Cancer|March 11, 2022
Safety of MET Tyrosine Kinase Inhibitors in Patients With MET Exon 14 Skipping Non-small Cell Lung Cancer: A Clinical ReviewAlexis Cortot, Xiuning Le, Egbert Smit, et al.
Future Oncology (London, England)|March 31, 2023
Plain language summary of the development of tepotinib: a treatment for a subtype of non-small cell lung cancer called <i>MET</i> exon 14 skippingJohn Hallick, Anne-Marie Baird, Gerald Falchook, et al.
CA: a Cancer Journal for Clinicians|July 17, 2025
Personalized care for patients with EGFR-mutant nonsmall cell lung cancer: Navigating early to advanced disease managementMaxime Borgeaud, Timothée Olivier, Jair Bar, et al.
JCO Precision Oncology|June 18, 2026
Real-World Patient Characteristics, Mutational Landscape, and Outcomes in Advanced/Metastatic <i>HER2</i>-Mutant Non-Small Cell Lung CancerChristine M Lovly, Christina Baik, Misako Nagasaka, et al.
Journal of Thoracic Disease|September 4, 2018
A consensus on the role of osimertinib in non-small cell lung cancer from the AME Lung Cancer Collaborative GroupTao Jiang, Chunxia Su, Shengxiang Ren, et al.
European Journal of Cell Biology|June 24, 2009
Interaction of SH3P13 and DYDC1 protein: a germ cell component that regulates acrosome biogenesis during spermiogenesisShuchun Li, Yuan Qiao, Qian Di, et al.
European Journal of Cell Biology|December 1, 2018
Corrigendum to "Interaction of SH3P13 and DYDC1 protein: a germ cell component that regulates acrosome biogenesis during spermiogenesis" [Eur. J. Cell Biol. 88 (2009) 509-520]Shuchun Li, Yuan Qiao, Qian Di, et al.
Pageof 18